Navigation Links
Mid*Lands IRB, LLC - First Independent IRB in Kansas and the Kansas City Area Awarded Accreditation for Protecting Research Participants
Date:10/22/2010

OVERLAND PARK, Kan., Oct. 22 /PRNewswire/ -- Mid*Lands IRB, LLC is pleased to announce that it has been awarded accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) at the September meeting of its Council on Accreditation.  

Located in the Kansas City metro area, Mid*Lands is an independent review board (IRB) that protects the rights and welfare of research study participants. Mid*Lands IRB specializes in providing customized, personalized, and responsive services for its client partners.  Mid*Lands provides IRB review for clients nationwide for all phases of research in all therapeutic areas.  Mid*Lands has extensive experience in multi-site trials, with two Boards that meet weekly.  

AAHRPP promotes high-quality, ethically sound research through an accreditation process that helps organizations worldwide strengthen their human research protection programs (HRPPs).

An independent, non-profit accrediting body, AAHRPP uses a voluntary, peer-driven, educational model to ensure that HRPPs meet rigorous standards for quality and protection. To earn accreditation, organizations must provide tangible evidence through policies, procedures, and practices of their commitment to scientifically and ethically sound research and continuous improvement.

As the "gold seal," AAHRPP accreditation offers assurances to research participants, researchers, sponsors, government regulators, and the general public that an HRPP is focused first and foremost on excellence.

"After a tremendous amount of work by both our staff and our IRB Members, Mid*Lands has achieved full accreditation," according to Cathy Owen, CIM, CIP, CCRP, President and CEO of Mid*lands. "The rigorous and comprehensive accreditation mandated by AAHRPP provides Mid*Lands with the ability to achieve even higher levels of protection for human research participants," Ms. Owen said.

For more information about Mid*Lands IRB, please visit our website at www.midlandsirb.com or contact:Cathy Owen, CIM, CIP, CCRPPresident & CEO913-385-1414cathyo@midlandsirb.com
'/>"/>

SOURCE Mid*Lands IRB, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion Will Host an Earnings Conference Call on Nov. 2 to Discuss the Results for the First Quarter Fiscal 2011
2. Quark Pharmaceuticals Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007
3. Cipla Launches the Worlds First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis)
4. Perrigo Company Will Release First Quarter Fiscal 2011 Results on November 2, 2010
5. Aircraft Medical Launches Worlds First Low Cost Video Laryngoscope
6. Cellectis Publishes Its Financial Statement for the First Half of 2010
7. Southeastern Michigan Gets First Ever FDA Approved Device That Destroys Fat Cells ... Without Surgery
8. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2011 Results
9. Cardiogenesis Enrolls First Two Patients in Its Feasibility Study of the PHOENIX® Combination Delivery System
10. Netsmart Technologies is First Behavioral Healthcare Software Provider to Pass Final Rule ARRA Certification Tests
11. Incept BioSystems Completes First Human Clinical Trial of the SMART Start™ Embryo Culture System and Submits 510(k) Application to the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... ROCKVILLE, Md. , July 13, 2017  New York ... watchers of pharmaceutical markets should be aware of.  From new ... These trends are detailed in a recently completed study, ... following: 1.  Age-Driven ... years, we have been aware of the impact the growing ...
(Date:7/12/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... to resolve pending patent litigation in the U.S. District Court ... regarding the Cialis ® (tadalafil) unit dose patent. This ... As part of the agreement, Cialis exclusivity is now expected ... "The unit dose patent for Cialis is valid and ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... July 19, 2017 , ... ... a larger audience and increased funds raised to support fine arts programs in ... “Disney Aladdin Kids” in Freed-Hardeman University’s Loyd Auditorium. , More than 850 ...
(Date:7/20/2017)... ... July 19, 2017 , ... Adolfson & ... project manager, Josh Christensen. As a leader in healthcare construction, AP has successfully ... healthcare resume in the Midwest with Josh now on board. , Josh ...
(Date:7/18/2017)... (PRWEB) , ... July 18, 2017 , ... CannaKids, a ... extracted cannabis oils, announced today that at the WORLDZ Summit, taking place in ... speaking on the therapeutic benefits of medical cannabis for both pediatric and adult patients, ...
(Date:7/18/2017)... ... , ... An inventor from Anacortes, Wash., knows the difficulties and indignity of ... flashes, and I suffer from anxiety and vertigo on top of that," she said, ... about." INSTA-FAN meets that need. , This device enables a woman in menopause to ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... and Its Treatments during Pregnancy , studies take a closer look at maternal ... a developing baby with one study showing newer medications may be safer choices. ...
Breaking Medicine News(10 mins):